🟢 Standard Biotools is trading 5.2% up today following the Federal Reserve decision and improved sentiment

Standard Biotools is trading 5.2% higher at $0.75 amid broad risk-on sentiment.

• Major indices are higher, with the S&P 500 up 0.94% and Nasdaq Composite up 1.49%.
• No new company-specific announcement was identified for September 17, 2026; recent merger and financial news are not fresh catalysts.
• The move therefore appears primarily market-driven, following the Federal Reserve decision and improved investor sentiment.